Irbesartan in mild to moderate hypertensive patients.

Trial Profile

Irbesartan in mild to moderate hypertensive patients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Mar 2011

At a glance

  • Drugs Irbesartan; Irbesartan/hydrochlorothiazide
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms I-SAVE
  • Sponsors Sanofi
  • Most Recent Events

    • 28 May 2008 Status changed from in progress to completed, according to ClinicalTrials.gov.
    • 10 Apr 2008 The expected completion date for this trial is now 1 Jun 2008 as reported by ClinicalTrials.gov.
    • 30 Oct 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top